ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980

Community-Based Program Final Planning Review In August, October

August 6, 1976

In Brief: Magnuson Subcommittee Increases NCI, NIH Budgets Despite Trimming Labor-HEW Bill By $250 Million

August 23, 1974

In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69

August 12, 1988

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997